IMMUNE RESPONSE BIOPHARMA, INC.

NEW YORK, NY How do I update this listing?

Immune Response Biopharma is based out of New York. The firm last filed a Form D notice of exempt offering of securities on 2012-08-14. The notice included securities offered of Equity,Debt,Option, Warrant or Other Right to Acquire Another Security

Create Alert

Contact Info

immune response biopharma, inc.
244 5TH AVENUE SUITE 1727
NEW YORK NY    10001

Business Phone: 5407600535

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2012-08-14 D PHARMACEUTICALS Equity,Debt,Option, Warrant or Other Right to Acquire Another Security 1,000,000,000 0 1,000,000,000
2011-08-02 D PHARMACEUTICALS Equity,Debt 1,000,000,000 0 1,000,000,000
2011-08-02 D/A PHARMACEUTICALS Equity,Debt 1,000,000,000 0 1,000,000,000
2011-07-01 D PHARMACEUTICALS Equity,Debt 10,000,000 0 10,000,000
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
DAVID ROBERT BUSWELL subscription required
    EXECUTIVE OFFICER

Elevate your investments